DE69829062D1 - Verwendung von flunarizin zur topischen behandlung ocularem hochdruck - Google Patents

Verwendung von flunarizin zur topischen behandlung ocularem hochdruck

Info

Publication number
DE69829062D1
DE69829062D1 DE69829062T DE69829062T DE69829062D1 DE 69829062 D1 DE69829062 D1 DE 69829062D1 DE 69829062 T DE69829062 T DE 69829062T DE 69829062 T DE69829062 T DE 69829062T DE 69829062 D1 DE69829062 D1 DE 69829062D1
Authority
DE
Germany
Prior art keywords
flunarizine
flunarizin
ocular
high pressure
topical treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69829062T
Other languages
English (en)
Other versions
DE69829062T2 (de
Inventor
Giuseppe Lisi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Medidom SA
Original Assignee
Laboratoire Medidom SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Medidom SA filed Critical Laboratoire Medidom SA
Application granted granted Critical
Publication of DE69829062D1 publication Critical patent/DE69829062D1/de
Publication of DE69829062T2 publication Critical patent/DE69829062T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
DE69829062T 1997-10-10 1998-10-06 Verwendung von flunarizin zur topischen behandlung ocularem hochdruck Expired - Lifetime DE69829062T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97RM000613A IT1295423B1 (it) 1997-10-10 1997-10-10 Uso della flunarizina nella terapia topica del glaucoma
ITRM970613 1997-10-10
PCT/IT1998/000266 WO1999018963A1 (en) 1997-10-10 1998-10-06 Use of flunarizine for the topical treatment of glaucoma

Publications (2)

Publication Number Publication Date
DE69829062D1 true DE69829062D1 (de) 2005-03-24
DE69829062T2 DE69829062T2 (de) 2006-02-09

Family

ID=11405290

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69829062T Expired - Lifetime DE69829062T2 (de) 1997-10-10 1998-10-06 Verwendung von flunarizin zur topischen behandlung ocularem hochdruck

Country Status (16)

Country Link
US (1) US6380198B1 (de)
EP (1) EP1021184B1 (de)
JP (1) JP4475802B2 (de)
AT (1) ATE289198T1 (de)
AU (1) AU734137B2 (de)
BR (1) BR9813855A (de)
CA (1) CA2306371C (de)
CZ (1) CZ294314B6 (de)
DE (1) DE69829062T2 (de)
ES (1) ES2237852T3 (de)
HU (1) HU227940B1 (de)
IT (1) IT1295423B1 (de)
PL (1) PL192217B1 (de)
PT (1) PT1021184E (de)
SK (1) SK285200B6 (de)
WO (1) WO1999018963A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001228863A1 (en) * 2000-01-31 2001-08-14 Santen Pharmaceutical Co. Ltd. Remedies for ophthalmic diseases
EP2319493A3 (de) * 2002-07-23 2011-07-27 Novartis AG Ophthalmische Salbenzusammensetzung , einen Wirkstoff, eine Salbengrundlage und eine Löslichkeits-/Dispergierbarkeitsvermittler enthaltend
AU2005282028B2 (en) * 2004-09-10 2011-03-24 Newron Pharmaceuticals S.P.A. (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
NZ567540A (en) * 2005-12-22 2010-07-30 Newron Pharm Spa 2-Phenylethylamino derivatives as calcium and/or sodium channel modulators
WO2007076358A1 (en) * 2005-12-23 2007-07-05 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
HUE030031T2 (en) 2011-06-27 2017-04-28 Newron Pharm Spa Fluorinated arylalkylaminocarboxamide derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07508030A (ja) 1992-05-13 1995-09-07 アルコン　ラボラトリーズ，インコーポレイテッド カルシウムアンタゴニストと公知の抗緑内障薬との組合せを含む眼局所用組成物

Also Published As

Publication number Publication date
CZ294314B6 (cs) 2004-11-10
US6380198B1 (en) 2002-04-30
IT1295423B1 (it) 1999-05-12
BR9813855A (pt) 2000-09-19
PL339453A1 (en) 2000-12-18
EP1021184A1 (de) 2000-07-26
HUP0003803A3 (en) 2001-12-28
AU9643398A (en) 1999-05-03
WO1999018963A1 (en) 1999-04-22
HU227940B1 (hu) 2012-06-28
ES2237852T3 (es) 2005-08-01
ATE289198T1 (de) 2005-03-15
CA2306371C (en) 2008-12-02
JP4475802B2 (ja) 2010-06-09
SK4992000A3 (en) 2000-12-11
ITRM970613A1 (it) 1999-04-10
JP2001519394A (ja) 2001-10-23
PL192217B1 (pl) 2006-09-29
PT1021184E (pt) 2005-06-30
AU734137B2 (en) 2001-06-07
CA2306371A1 (en) 1999-04-22
SK285200B6 (sk) 2006-08-03
EP1021184B1 (de) 2005-02-16
DE69829062T2 (de) 2006-02-09
CZ20001213A3 (cs) 2000-07-12
HUP0003803A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
HK1015691A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia.
ES2042625T3 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
EP1348437A3 (de) Prostaglandinderivative zur Behandlung von Glaukoma oder okuläre Hypertension
LU92058I2 (fr) Travoprost et ses sels pharmaceutiquement acceptables (TRAVATAN®)
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
ATE223200T1 (de) Einen carboanhydrase-hemmer und xanthangummi enthaltendes augenarzneimittel
DE69829062D1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
DE69705421D1 (de) 15-fluoro-prostaglandine als augendrucksenkende mittel
DE69323202T2 (de) Ophthalmologische zubereitungen
HK1024170A1 (en) Remedial composition for intraocular hypertension or glaucoma
BR9901566A (pt) Análogos cis-delta4 de prostaglandinas como hipotensores oculares

Legal Events

Date Code Title Description
8364 No opposition during term of opposition